News|Articles|May 8, 2026

Amazon Pharmacy Now Offering Same-Day Delivery for Ozempic Pill

Listen
0:00 / 0:00

Key Takeaways

  • Oral semaglutide enables ambient storage, supporting in-office pharmacist-supported kiosks and same-day fulfillment, which can compress the prescribing-to-dispensing interval and reduce traditional pharmacy bottlenecks.
  • Expansion from ~3,000 to ~4,500 locales is positioned as an access strategy, including rural reach, backed by a $4B logistics investment and integrated One Medical touchpoints.
SHOW MORE

The weight-loss and diabetes drug will now be available via Amazon Pharmacy for same-day delivery or in-person kiosk pickup.

Amazon Pharmacy announced yesterday it will now offer oral semaglutide (Ozempic) for same-day delivery or in-person pickup at its kiosks, significantly expanding access to the booming glucagon-like peptide-1 (GLP-1) for millions of patients in need. Patients will also receive real-time transparent pricing on the medication as well as manufacturer-sponsored savings, according to an Amazon News release.1

“Expanding access to GLP-1 medications through more convenient delivery models can help patients better manage obesity and cardiometabolic health conditions,” Sara Izadi, PharmD, chief clinical officer at Judi Health, told Drug Topics®. “It’s not just about improving convenience; it’s about ensuring patients get the right medications at the right time, while equipping them with the tools and support they need to make sustainable lifestyle changes. That’s how we improve patient outcomes and reduce the total cost of care.”

The move by Amazon to stock the oral version of semaglutide is a strategic response to the logistical challenges of the cold-chain supply. Unlike the injectable Ozempic 1 mg dose pens, which require constant refrigeration and are delivered through Amazon’s standard pharmacy mail service, the oral tablets can be stored in ambient conditions.2,3

This stability allows the medication to be stocked within in-office, licensed, pharmacist-supported kiosks located at select One Medical locations.1

READ MORE: GLP-1s Made Up Eight Of Every 100 Prescriptions Filled in March 2026

For practicing pharmacists, this shifts the point of care, as patients can now pick up their prescriptions within minutes of a medical appointment, bypassing pharmacy wait times. Amazon has committed to expanding this same-day service from 3000 cities to approximately 4500 locales by the end of the year, backed by a $4 billion investment aimed at reaching underserved rural areas.1,2

Clinical pharmacists must also navigate the widening therapeutic applications of the GLP-1 class. Although Ozempic is primarily FDA-approved for glycemic control in type 2 diabetes (T2D), its active ingredient, semaglutide, has a pleiotropic effect across multiple organ systems, including the cardiovascular and renal systems.3,4

Research indicates that these medications are being utilized for a range of conditions beyond diabetes, including clinically meaningful weight loss, chronic kidney disease, and obstructive sleep apnea. Recent findings even suggest potential applications for metabolic-associated steatotic liver disease (MASLD) and substance use disorders, according to Current Atherosclerosis Reports.4

However, this expanding usage has led to a significant increase in off-label usage. Approximately 33% of Ozempic patients have no history of diabetes, as many health care providers prescribe the drug to meet the high demand for weight management solutions.4,5

This surge in demand has created a complex landscape for medication access and health equity. According to the USC Leonard D. Schaeffer Institute for Public Policy & Government Service, although wide access to GLP-1s could generate nearly $1 trillion in cumulative social benefits and significantly increase life expectancy for young adults, significant disparities remain.6

Data shows that White patients are 4 times more likely than Black patients to receive a semaglutide prescription, despite higher rates of obesity and diabetes in Black and Hispanic communities. Cost remains a primary barrier, though Amazon is attempting to address this through transparent pricing, offering a $149 monthly cash price for the oral tablet compared with the significantly higher wholesale prices often associated with injectables.1,4-6

However, for the pharmacists and pharmacy owners not affiliated with Amazon Pharmacy, not everyone is on-board with the major conglomerate’s kiosk and mail-order business.

“It feels like brick and mortars are being put aside when using a kiosk,” Brian Walker, RPh, owner of Delmar Pharmacy in Folcroft, Pennsylvania, told Drug Topics®. “As store owners, we know all of our patients' meds are available to answer questions, and frankly, when we bypass the store, we lose out on offering clinical weight-loss programs, OTCs, lottery sales, etc. Decreased foot traffic decreases our revenue.”

For the dispensing pharmacist, counseling remains a critical component of the Amazon Pharmacy model, which provides 24/7 access to licensed professionals to discuss potential interactions and adverse events.1,3

As the supply chain continues to struggle with demand, often leaving some doses currently unavailable, pharmacists play a vital role in managing patient expectations and suggesting therapeutic alternatives when necessary. By integrating advanced delivery logistics with continuous clinical support, this new model aims to improve adherence and long-term health outcomes for a patient population that has grown by 40-fold in its use of GLP-1 medications over recent years.3,5,6

“Industry collaborations like the one Amazon Pharmacy has with Novo Nordisk are important in expanding access to life-saving medications like the Ozempic pill to treat T2D, especially for customers living in growing pharmacy deserts,” Tanvi Patel, vice president and general manager of Amazon Pharmacy, told Drug Topics®. “Amazon Pharmacy is making it simpler for customers to fill their prescriptions with transparent pricing, real-time medication availability, automatic manufacturer coupon application and caregiver tools that make it easier to manage medications for loved ones.”

READ MORE: Diabetes Resource Center

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips straight to your inbox.

REFERENCES
1. Amazon Pharmacy expands access to new Ozempic® pill via same-day delivery, kiosks. Amazon News. News Release. May 7, 2026. Accessed May 8, 2026. https://press.aboutamazon.com/2026/5/amazon-pharmacy-expands-access-to-new-ozempic-pill-via-same-day-delivery-kiosks
2. Niasse A. Amazon to carry Ozempic at US kiosks, offer same-day delivery. Reuters. May 7, 2026. Accessed May 8, 2026. https://www.reuters.com/business/healthcare-pharmaceuticals/amazon-carry-ozempic-us-kiosks-offer-same-day-delivery-2026-05-07/
3. Ozempic, 1 mg dose pen Injector. Amazon. 2026. Accessed May 8, 2026. https://pharmacy.amazon.com/Novo-Nordisk-OZEMPIC-1-MG-DOSE-PEN-INJECTOR-Box-3-Milliliter/dp/B084BW1KST
4. Sheth K, Kim S, Porterfield L, et al. The expanding scope of GLP-1 receptor agonists: six uses beyond diabetes. Curr Atheroscler Rep. 2025 Jul 30;27(1):76. doi: 10.1007/s11883-025-01319-6.
5. Logan P. On the increase in use of GLP-1s. Indiana University School of Medicine. June 27, 2024. Accessed May 8, 2026. https://medicine.iu.edu/blogs/bioethics/on-the-increase-in-use-of-glp-1s
6. Ward AS. The case for expanding access to weight-loss medications. USC Leonard D. Schaeffer Institute for Public Policy & Government Service. March 12, 2026. Accessed May 8, 2026. https://schaeffer.usc.edu/research/the-case-for-expanding-access-to-weight-loss-medications/

Latest CME